CHM.C - Chemistree Technology

[Frederick_Chabot]

Résumé:

http://chemistree.ca/

STRATÉGIE CORPORATIVE DE CHEMISTREE DANS L’ÉTAT DE WASHINGTON - DÉTENIR DES ACTIFS, SOUTENIR LES PRODUCTEURS

Les restrictions en vertu de la réglementation I-502 de l’État de Washington interdisent à l’entreprise et / ou à ses ses filiales d’avoir un intérêt direct sur les revenus provenant de la production, de la transformation ou de la vente au détail de marijuana dans l’État de Washington.

Une entreprise et / ou ses filiales peuvent toutefois louer des biens et octroyer des licences pour ses marques, ses services de production et de conseil aux détenteurs de permis de marijuana agréés de l’État de Washington.

Chemistree a identifié une opportunité unique dans l’industrie de culture et de transformation du cannabis dans l’État de Washington et a signé une lettre d’intention avec des parties indépendantes pour acquérir une suite d’actifs utilisés dans la culture, la production, la distribution et l’image de marque du cannabis. les actifs utilisés dans l’exploitation de la marque Sugarleaf.

Dans un processus parallèle et sous réserve de l’acquisition de l’actif, un partenaire stratégique de Chemistree, basé à Washington, acquerra la licence de producteur / transformateur I-502 Tier 3 de Washington State n ° 423406 de Sugarleaf Farm, LLC.

La société, par l’intermédiaire de Chemistree Washington Ltd., s’attend également à ce qu’elle investisse dans l’immobilier de l’État de Washington et le développe dans le but de desservir des entreprises de production et de transformation sous licence I-502.

En plus de fournir des installations spécialisées aux producteurs et aux transformateurs I-502, la Société entend développer ses techniques de culture, ses procédures d’exploitation normalisées et ses pratiques de fabrication novatrices pour aider les titulaires de permis dans leurs activités de production et de transformation. La société est d’avis que ces services créeront des synergies et des avantages qui procureront des revenus importants et à long terme au titulaire de licence et, par le fait même, à la société.

Placement privé et acquisition de SUGARLEAF

Financement par placement privé sans courtier

Chemistree est également heureuse d’annoncer un financement sans courtiers pour lever jusqu’à 2,1 millions de dollars. L’offre sera sans intermédiaire et consistera en un maximum de six millions d’unités au prix de 0,35 $ l’unité. Chaque unité sera composée d’une action ordinaire et d’un bon de souscription d’actions ordinaires (un «bon de souscription»); chaque bon de souscription permettra à son porteur d’acquérir une action ordinaire supplémentaire au prix de 0,50 $ pour une période de 24 mois après la clôture du placement privé. Les bons de souscription sont assujettis à une disposition d’accélération selon laquelle le cours de clôture des actions ordinaires de la Société sur le CSE est supérieur à 0,60 $ par action ordinaire pendant une période de dix (10) jours de transactions consécutifs (un «événement déclencheur»), la Société peut alors émettre un avis (l '«Avis d’Accélération») aux détenteurs de bons de souscription leur notifiant que les bons de souscription doivent être exercés dans les trente (30) jours calendaires suivant la date de l’Avis d’Accélération, sinon les Warrants expireront à 16:00 heures (Heure de Vancouver) le trentième (30e) jour suivant la date de l’avis d’accélération.

Le produit net du placement privé sera ajouté au fonds de roulement général, dont certains devraient être déployés pour fermer l’acquisition d’actifs à Washington. Toutefois, la clôture du placement privé n’est pas conditionnelle à la réalisation de l’acquisition de l’actif de Washington, et la Société aura le pouvoir discrétionnaire d’utiliser le produit différemment si elle croit qu’il est dans son intérêt de le faire.

Les actifs de SUGARLEAF

Suite complète des actifs opérationnels utilisés. Coût de remplacement approximatif de plus de 1 500 000 USD

Sugarleaf - Informations Financières

2017

Production de cannabis -1,938 lb
Revenus - 1 370 000 USD
Ventes brutes 707 $ / lb
COGS 600 $ / lb

2018 estimé

Production de cannabis -2.200 lbs
Revenus - 2 200 000 USD
Ventes brutes 1 000 $ / lb
COGS 600 $ / lb

Cible 2019

Production de cannabis
Revenus - 3 500 000 $ US
Ventes brutes 900 $ / lb
COGS 600 $ / lb

Renseignements sur les installations de Sugarleaf

2018

Opération intérieure de 5 000 pieds carrés
409 lumières au total
288 lumières pour floraison

2019

Opération intérieure de 10 000 pieds carrés
5 000 pieds carrés ajoutés pour localiser les opérations de traitement
et laboratoire de test.
Production supplémentaire grâce à l’efficacité et à l’espace supplémentaire
Produits de Sugarleaf dans plus de 50 magasins de détail
Plan de marketing pour augmenter à plus de 100 magasins d’ici la fin de 2018
Objectif 2019 de plus de 200 magasins
Des lignes de produits supplémentaires et des offres élargies au sein des marques actuelles

Situation financière:

INFORMATIONS SUR LE CAPITAL-ACTIONS - DISTRIBUTION DU GROUPE

Groupe de gestion et Consultants - 65%

ÉMISSIONS ANTÉRIEURES Automne 2017 6 190 800 actions ordinaires 0,255 $ pour un montant de 1 547 700 $

Actions émises 22 289 205 entièrement diluées

En Conclusion

Deux grosse pointures se sont ralliés à cette histoire soit Justin Chorbajian propriétaire de Green Planet et Dennis Hunter propriétaire de la spectaculaire CannaCraft. Considérant que l’avenir de cette industrie se situera dans la mise en marché et l’accès aux consommateurs, Chemistree est fortement appuyé par son management.

Par ailleurs au terme de ce placement la valorisation vis à vis ses pairs est très basse ce qui donne beaucoup de jeu pour un réajustement vers le haut dans les mois à suivre.

Divulgation: Actionnaire de la compagnie et participera au Placement actuel.

[Luc]

sont-ils clients de contact financials?

[Frederick_Chabot]

[Frederick_Chabot]

https://ceo.ca/@nasdaq/chemistree-closes-2559820-first-tranche-of-non-brokered

Chemistree Closes $2,559,820 First Tranche of Non-Brokered Private Placement Financing

This press release is not to be distributed to U.S. newswire services or to be disseminated in the United States.

VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that effective June 25, 2018, it has closed the first tranche of the non-brokered private placement as announced May 11, 2018 and as amended June 22, 2018, in the amount of $2,559,820.

The first tranche was comprised of 7,313,771 units, issued at $0.35 per unit for gross proceeds of $2,559,820. Each unit consists of one common share and one common share purchase warrant; each warrant will entitle the holder to acquire one additional common share for 50 cents for a period of 24 months after closing of the private placement. The warrants are subject to an acceleration provision whereby if the closing market price of the common shares of the company on the Canadian Securities Exchange is greater than 60 cents per common share for a period of 10 consecutive trading days, then the company may deliver a notice to the holders of warrants notifying the holders that the warrants must be exercised within 30 calendar days from the date of the acceleration notice, otherwise the warrants will expire at 4 p.m. PT on the 30th calendar day after the date of the acceleration notice.

The Company also issued 438,464 Finder’s Warrants in connection with the placement and the warrants will have the same terms as the common share purchase warrants included in the placement units. Securities issued under the placement are subject to a four-month hold period, which will expire four months from the date of closing.

Immediately following this private placement issuance, the Company has 28,652,976 common shares issued and outstanding.

The net proceeds of the private placement will be added to general working capital, some of which are expected to be deployed to close the Washington asset acquisition. However, the closing of the private placement is not conditional upon the completion of the Washington asset acquisition, and the Company will have discretion to use the proceeds differently if it believes it is in its best interests to do so.

The units, common shares and Warrants have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirement of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the units, common shares or Warrants, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, will be included in the Form 2A listing statement to be filed with the CSE.

For more information, please contact Paul Searle at (778) 240-7724 or by email at paul@chemistree.ca.

“Karl Kottmeier”
President

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the
policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of
this news release.

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “budget”, “scheduled” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about adding clients, building on the Company’s initial product offerings, entry into of definitive agreements for the asset acquisition, the timing and completion of the asset acquisition, receipt of shareholder, regulatory and CSE approvals for the asset acquisition and change of business, and the size and completion of the non-brokered private placement and the use of proceeds therefrom. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators, that the Company may not complete the asset acquisition, failure to obtain CSE, shareholder or regulatory approvals for the asset acquisition, the Strategic Partner may fail to obtain WSLCB approval when expected or at all or may fail to acquire the Sugarleaf License on the terms and timing expected or at all, the Company may fail to enter into agreements with the Strategic Partner on the terms and timing and for the services expected or at all and changes to U.S. federal law or Washington State law or enforcement practices relating to cannabis. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

[Frederick_Chabot]

Chemistree Increases Private Placement Financing a Second Time

-closes Washington State acquisition
-engages investor relations teams
-stock options granted

This press release is not to be distributed to U.S. newswire services or to be disseminated in the United States.

VANCOUVER, British Columbia, July 10, 2018 (GLOBE NEWSWIRE) – Chemistree Technology Inc. (Canadian Securities Exchange:CHM) (US OTCQB:CHMJF) (the “Company” or “Chemistree”) announced that in conjunction with the final closing of the private placement announced May 11 and June 22, 2018, it has again increased the size of its non-brokered private placement. Chemistree now plans to increase the size of the placement via the issuance of up to an aggregate of thirteen million units at a price of $0.35 per unit, for gross proceeds of up to $4,550,000. Each unit will be comprised of one common share and one common share purchase warrant (a “Warrant”); each Warrant will entitle the holder to acquire one additional common share for $0.50 for a period of 24-months after closing of the private placement. The Warrants are subject to an acceleration provision whereby if the closing market price of the Common Shares of the Company on the Canadian Securities Exchange (the “Exchange”) is greater than $0.60 per Common Share for a period of ten (10) consecutive trading days (a “Trigger Event”), then the Company may deliver a notice (the “Acceleration Notice”) to the holders of Warrants notifying the holders that the Warrants must be exercised within thirty (30) calendar days from the date of the Acceleration Notice, otherwise the Warrants will expire at 4:00 p.m. (Vancouver time) on the thirtieth (30th) calendar day after the date of the Acceleration Notice.

The Company plans to close the second and final tranche of the placement tomorrow.

The net proceeds of the private placement will be added to general working capital. Closing of the private placement is subject to receipt of all necessary approvals and definitive subscriptions. All units, common shares and Warrants issued under the private placement will be subject to a four-month hold period from the closing date, in accordance with applicable Canadian securities laws.

The units, common shares and Warrants have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirement of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the units, common shares or Warrants, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Washington Acquisition
Further to the definitive asset purchase agreement announced on June 1, 2018, the Company has completed, through its wholly owned subsidiary, Chemistree Washington Ltd. (“Chemistree Washington”), the purchase of a suite of Washington-based assets used in cannabis cultivation, production, distribution and branding.

Chemistree Washington entered into a definitive asset purchase agreement with Elite Holdings Inc. with respect to the Washington acquisition. Pursuant to the Washington acquisition agreement, Chemistree Washington acquired certain assets, including, but not limited to, all inventory, leases, software, furniture, systems, equipment and lighting from the Washington vendor. The acquisition does not include any receivables, payables, warranties, employee or tax liabilities of the Washington vendor.

Investor Relations Arrangements
Chemistree is also pleased to announce that it has entered into consulting agreements with Contact Financial Corp. and Adelaide Capital Markets Inc. (“IR Firms”) to provide investor relations and communication services. The Company has selected the IR Firms as experienced arm’s length firms that specialize in small-cap growth companies and will generate value by sharing Chemistree’s compelling story to wealth managers, brokers, institutions, analysts, portfolio managers, retail and high net worth clients globally. Contact Financial, headed by Kirk Gamley, is based in Vancouver, British Columbia, and Adelaide Capital, Markets headed by Deborah Honig and Jackie Kelly, is based in Toronto, Ontario.

In addition to the contracted compensation, and subject to Exchange approval, Chemistree has agreed to grant Contact Financial and Adelaide Capital Markets options to acquire 150,000 and 100,000 common shares, respectively, in the capital of the Company at a price of $0.41 per share that vest quarterly over twelve months and have a five-year term.

Other than 1,400,000 common shares and 200,000 warrants held directly and indirectly by Contact Financial, none of Contact Financial, Adelaide Capital Markets or their respective owners has any interest, directly or indirectly, in the Company or its securities, or any right or intent to acquire such an interest, other than the above stock option grants.

Option Grant
Pursuant to the Company’s stock option plan, the Company has granted options to purchase 250,000 common shares at $0.41 per share to certain eligible officers and consultants. The options expire in five years.

The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws.

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, will be included in the Form 2A listing statement to be filed with the CSE.

“Karl Kottmeier”
President

For further information please contact:
Chemistree Technology Inc.
Karl Kottmeier, President
Phone: 604-678-8941
Email: info@chemistree.ca
Suite 810 – 609 Granville Street
Vancouver, BC V7Y 1G5

For investor relations please contact:
Contact Financial Corp.
Rob Gamley
Phone: 604-689-7422
Email: rob@contactfinancial.com

Adelaide Capital Markets Inc.
Jackie Kelly
Phone: 416-301-2949
Email: jackie@adelaidecapital.ca

Chemistree Completes Final Tranche of Private Placement Financing

Chemistree Completes Final Tranche of Private Placement Financing

VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) – Chemistree Technology Inc. (Canadian Securities Exchange:CHM) (US OTCQB:CHMJF) (the “Company” or “Chemistree”) is pleased to announce that effective July 11, 2018, it has closed the final tranche of the non-brokered private placement as announced May 11, and as amended June 22, and July 10, 2018, for gross proceeds of $1,949,365. Gross proceeds from the two closings aggregate $4,509,184, which has been added to general working capital.

The July 11, 2018, final tranche was comprised of 5,569,613 units, issued at $0.35 per unit. Each unit consists of one common share and one common share purchase warrant; each warrant will entitle the holder to acquire one additional common share for $0.50 cents for a period of 24 months after closing of the private placement. The warrants are subject to an acceleration provision whereby if the closing market price of the common shares of the Company on the Canadian Securities Exchange (the “CSE”) is greater than $0.60 per common share for a period of 10 consecutive trading days, then the Company may deliver a notice to the holders of warrants notifying the holders that the warrants must be exercised within 30 calendar days from the date of the acceleration notice, otherwise the warrants will expire at 4:00 p.m. PT on the 30th calendar day after the date of the acceleration notice.

The Company also issued 257,748 Finder’s Warrants in connection with the final tranche, and the warrants will have the same terms as the common share purchase warrants included in the placement units. Securities issued under the placement are subject to a four-month hold period, which will expire four months from the date of closing. Immediately following this private placement issuance, the Company has 34,222,589 common shares issued and outstanding.

The units, common shares and Warrants have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirement of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the units, common shares or Warrants, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Change of Business Filing
On June 27, 2018, Chemistree received conditional approval from the CSE for its change of business from a Technology Issuer to an Investment Issuer, which was deemed a fundamental change under CSE Policy 8. With the completion of the private placement financing, the Company has met all the conditions set-out by the CSE. In due course following submission and acceptance of the final documentation required by the CSE, the Company expects that the CSE will reinstate trading in the Company’s common shares. Following final approval by the CSE, the Company expects to issue a further news release announcing final approval by the CSE and the reinstatement of trading.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, providing turn key solutions for the U.S. regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated U.S. cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities throughout the U.S. The Company currently owns assets in Washington State used to operate the Sugarleaf brand and has a robust pipeline of assets to grow its base of business across the U.S. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, will be included in the Form 2A listing statement to be filed with the CSE.

“Karl Kottmeier”
President

For further information please contact:
Chemistree Technology Inc.
Karl Kottmeier, President
Phone: 604-678-8941
Email: info@chemistree.ca

For investor relations please contact:
Contact Financial Corp.
Rob Gamley
Phone: 604-689-7422
Email: rob@contactfinancial.com Adelaide Capital Markets Inc.
Jackie Kelly
Phone: 416-301-2949
Email: jackie@adelaidecapital.ca

[Frederick_Chabot]

Once-Iffy U.S.-Focused Pot Stocks Are Becoming Investor Darlings

Les élection mid-term aux USA vont jouer un rôle clef dans la légalisation au niveau Fédéral. Il faut être positionner sur cette opportunité qui sera 100 fois plus importante que ce qu’on a pu observer ici au Canada.

[Frederick_Chabot]

CHEMISTREE ANNOUNCES FORMAL CLOSING OF CALIFORNIA LAND PURCHASE

ANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has now closed the previously announced transaction to purchase 9.55 acres of bare land located within the Desert Hot Springs, California “Light Industrial Lands Designated for Marijuana Cultivation” area.

Chemistree, through its indirect, wholly-owned California subsidiary CHM Desert LLC, has received final notification that title to the DHS property has been transferred and escrow has now closed on the purchase contract with an arm’s length vendor for the purchase of 9.55 acres of fee simple, vacant land in the City of Desert Hot Springs, Riverside County, California (the “DHS property”). Consideration for the purchase was $1,233,800 USD.

The DHS property can support development plans and a Conditional Use Permit application for a total of three (3) 68,000 sq. ft cultivation and processing buildings on the site totaling approximately 205,000 sq. ft., together with the required ancillary space for parking, firefighting equipment and site security, based on the regulations of the City of Desert Hot Springs.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, providing turn key solutions for the U.S. regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated U.S. cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities throughout the U.S. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, and has a robust pipeline of assets to grow its base of business across the U.S. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE.

“Karl Kottmeier”
President

For further information please contact:
Chemistree Technology Inc.
Karl Kottmeier, President
Phone: 604-678-8941
Email: info@chemistree.ca

For investor relations please contact:
Contact Financial Corp.
Rob Gamley
Phone: 604-689-7422
Email: rob@contactfinancial.com Adelaide Capital Markets Inc.
Jackie Kelly
Phone: 416-301-2949
Email: jackie@adelaidecapital.ca

[Frederick_Chabot]

Chemistree Announces Strategic Investment in Pasha Brands

VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has made a strategic investment in Pasha Brands, via their current equity capital financing.

Pasha is a west coast company firmly established in B.C’s craft cannabis industry and all of the related brands that have given the region its international reputation as the center of the cannabis world. Pasha is a vertically integrated cannabis brand company with several internationally recognized brands, a proven history in cannabis retailing, and with its final stage LP applicant, BC Craft Supply Co., Pasha will own and operate a Health Canada approved Licensed Processing facility on Vancouver Island, where it will assist in licensing select craft growers and making world famous BC Bud available coast to coast. BC Craft Supply Co. will be Canada’s most productive LP, without growing a single gram.

Chemistree president Karl Kottmeier commented, “We are excited to support Pasha and begin what we believe will be a successful relationship with the company. We see a future where Pasha represents the brands Chemistree develops in California and Washington, including our partner brand Sugarleaf.”

The investment in Pasha amounts to less than 10% of both Chemistree’s working capital and the current Pasha financing.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Controlled Substances Act classifies “marihuana” as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE.

“Karl Kottmeier”
President

For further information please contact:
Chemistree Technology Inc.

Karl Kottmeier, President
Phone: 604-678-8941
Email: info@chemistree.ca||
|||
|For investor relations please contact:||
|Contact Financial Corp.
Frederick Chabot
Phone: 438-863-7071
Email: frederick@contactfinancial.com|Adelaide Capital Markets Inc.
Jackie Kelly
Phone: 416-301-2949
Email: jackie@adelaidecapital.ca|

[Frederick_Chabot]

PashaDeck[1]-min.pdf (2,2 Mo)

La Présentation de Pasha Brands

Pasha is a vertically integrated cannabis brand company with a
proven history in cannabis retailing, operating licensed stores throughout British Columbia.

Pasha owns and operates BC’s largest chain of licensed cannabis retail outlets operating
throughout Vancouver and will expand its reached into new municipalities in 2018. Pasha owns
Edo, a creative cannabis edibles company. With late stage LP applicant Royal Green Acres Ltd.,
Pasha will own and operate a Health Canada approved Licensed Production & Processing facility in
Nanaimo, BC, where it will assist in licensing select craft growers and making world famous BC Bud
available to the world.

Pasha will be Canada’s most productive licensed producer, without growing a single gram.

[Frederick_Chabot]

Sheldon Aberman Joins Chemistree Board of Directors

Sheldon est la Clef de Voûte de toute cette histoire. Si j’avais une compagnie modèle pour CHM ce serait CRZ CannaRoyalty.

Dear Canada: This is what marijuana legalization looks like in California

[Frederick_Chabot]

Succeeding in California cannabis: four questions with Chemistree Technologies president Karl Kottmeier

[Frederick_Chabot]

Trace écrite

[Frederick_Chabot]

Chemistree partners with Humboldt County, California cannabis processor

VANCOUVER, Nov. 27, 2018 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has entered into a strategic collaboration (the “Collaboration”) with a Humboldt County-based cannabis processing company (the “Processor”) located in Arcata, California. Pursuant to the Collaboration, Chemistree will loan the Processor US$450,000 (the “Loan”), and the parties also intend to negotiate an additional line of credit for working capital purposes. Chemistree expects the Processor will use the proceeds of the loan for business expansion, including to, among other things, purchase additional equipment and make tenant improvements to its facility.

Karl Kottmeier, Chemistree’s President, commented "This is a great advancement for Chemistree. Not only is the Processor a highly regarded service provider in the Humboldt cannabis industry, with deep relationships with local cultivators, we believe they are also primed for growth in their sector. We believe that Chemistree can provide capital and management depth to rapidly expand the Processor’s business, both in the local Humboldt area, across the state of California, and ultimately into new jurisdictions across the United States where legal cannabis processing and product development is in formative stages. Chemistree will also work with the Processor to purchase cannabis biomass on a proprietary basis and process that biomass to ultimately be sold as a Chemistree or Sugarleaf branded product.

The Processor holds a “Type 6: Non Volatile Solvent Extraction” license from the State of California. The Processor uses Apeks super critical CO2 extraction to produce cannabis oil, terpene profiles and other products on behalf of cannabis cultivators, other manufacturers and processors throughout northern California.

Chemistree expects to fund the Loan from its existing cash on hand. In addition, in consideration for benefits received by Chemistree under the Collaboration, it has agreed to issue 100,000 common shares to the principal of the Processor.

Additionally, Chemistree is pleased to announce it has engaged Native Ads to provide, manage and consult on a wide variety of marketing and digital marketing initiatives for the company.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

[Frederick_Chabot]

Une de mes plus importantes positions. Ce que je vois à l’horizon pour Chemistree sont quelques transactions d’ampleur qui vont définitivement mettre CHM dns la même catégorie que les compagnies cités dans cet article. Bon trading!

Why Companies Are Buying Up Assets in the American Cannabis Market

CannabisNewsWire Editorial Coverage: Canada became the first country in the G8 to legalize recreational cannabis. With all the buzz surrounding Canada’s cannabis boom, savvy investors have begun to assess the U.S. market, focusing on companies such as Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) (CHMJF Profile) , which in July 2018 purchased a suite of physical assets, currently under lease to Sugarleaf Farm LLC, a I-502 Tier 3 licensee located in Sedro Woolley, Washington. This moved was fueled by movement north in Canada, including large Canadian cannabis companies such as Origin House (CSE: OH) (OTCQX: ORHOF) and Namaste Technologies (TSX.V: N) (OTCQB: NXTTF) , which are already seeing major success as their products continue to sell well across the country. While newer entrants in the cannabis industry such as CannTrust Holdings (TSX: TRST) (OTC: CNTTF) and iAnthus Capital (CSE: IAN) (OTCQX: ITHUF) are creating their own product lines and playing catch up with major brands that consumers are already familiar with.
Establishing Brands Early

Large-scale cannabis legislation has never existed to the extent that it now does in Canada. With major Canadian companies creating brands that resonate with cannabis consumers.

The legal U.S cannabis market is worth an estimated $8.5 billion, claiming 90 percent of the entire $9.5 billion global market. Of that, sales of legal marijuana in Washington State have climbed up to $1.3 billion in the fiscal year 2017, up from $786 million in fiscal 2016, and $259 million the year before. The Canadian market was worth only 6 percent of that $9.5 billion total in 2017. In Canada, competition is heating up as the larger cannabis companies battle for their share of the market. They are relying on their brands and name recognition to help them achieve success.

However, the U.S. cannabis market is shaping up differently. Due to cannabis being federally illegal in the United States, cannabis companies are unable to ship their products across state lines. The unique state-by-state approach to legalization has provided Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF) with an ideal environment to build its brands through the production and sale of premium cannabis in California and Washington. It has also shielded American companies from an influx of foreign product.

Chemistree is another company that is focused on establishing quality brands. The company originally acquired Sugarleaf’s assets in Washington in order to augment its product line with a desirable premium brand. Sugarleaf is already featured in over 50 dispensaries within the state, with estimates suggesting that it will penetrate over 100 stores by 2018 and as many as 200 stores by 2019.

Sugarleaf’s signature White 99 strain has a THC level that registers between 28–32 percent. This is incredibly high even when compared to some of the premium cannabis strains that are being grown in Canada. Sugarleaf’s master grower, Jason Flynn, is one of the many reasons Chemistree chose to acquire the brand. Flynn and his team have won two consecutive cannabis cup competitions for their strains, including the 2014 People’s Choice (Presidential Kush) and 2015 People’s Choice (White 99).

Chemistree also managed to purchase property in the middle of California’s cannabis-friendly Desert Hot Springs for a reasonable $1.23 million. The site is large enough to support up to 205,000 square feet of greenhouses spread out across three facilities. Once fully operational, the company could produce nearly 50,000 pounds of cannabis per year. Desert Hot Springs is a popular cannabis region where there are 3.78 dispensaries for every one thousand people, which is the second highest pot shop density in the state.

Premium Cannabis Is the Real Asset

The demand for premium products exists as cannabis enthusiasts desire THC-rich strains in order to achieve a vivid sensory experience. Growing high-quality cannabis at scale is a challenge that many large producers struggle with as it costs more to produce, and the margin of error is higher.

Health Canada predicts that nearly 2.2 million pounds of cannabis will be consumed within Canada in 2018 alone. The majority of that cannabis will be low- and mid-grade quality, which wholesales for a lot less. Premium cannabis, while more difficult to grow, does provide companies that can grow it with higher profit margins. According to Deloitte, high-quality cannabis could sell for up to 12 percent more than lower quality flower.

The majority of the provinces have supply agreements in place with various licensed producers in the industry. These supply agreements were established in order to provide additional premium cannabis to those provinces.

Demand Will Only Increase

The U.S. cannabis sector is currently in its formative stages. Established companies within the industry that are preemptively laying the framework before the federal government legalizes recreational cannabis should have the ability to build brand recognition and scale them as the floodgates open.

Grand View Research predicts that the global cannabis market could be worth $146.4 billion by 2025. Companies such as Chemistree may be ideally positioned to take advantage of a larger global market because of its focus on building long-term brands that appeal to cannabis users.

Major Players in North American Cannabis

Origin House (CSE: OH) (OTCQX: ORHOF) is focused on creating global brands. It currently holds more than 50 brands including Bhang, Soul Sugar Soul Kitchen and Green Rock Botanicals, among others. The company has a distribution network of 4500plus dispensaries across the United States. With a suite of established brands across key markets in North America, Origin is actively developing infrastructure to support the proliferation of its brands internationally, initially through its acquisition of Canadian retailer 180 Smoke.

CannTrust Holdings (TSX: TRST) (OTC: CNTTF) is a relatively new Canadian cannabis company specializing in medical cannabis products including CBD- and THC-infused capsules and oils. CannTrust recently partnered with Breakthru Beverage Group’s subsidiary company Kindred to secure distribution through the Canadian adult consumer market.

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF) operates the largest global cannabis e-commerce platform with more than 30 websites in 20 countries under various brands. The company product offering through its subsidiaries — such as CannMart Inc., VapeBR, VaporSeller, etc. — includes vaporizers, glassware, accessories, CBD (cannabidiol) products and medical cannabis in the Canadian market.

iAnthus Capital (CSE: IAN) (OTCQX: ITHUF) is a U.S.-based licensed producer and cannabis retail company. iAnthus currently owns a 200,000-square-foot facility in Lake Wales, Florida, and a 4,500-square-foot dispensary in Palm Beach County, Florida. It is also planning to scale to more than 30 locations throughout the state in the coming years.

For more information on Chemistree, visit Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF)

Please also read and review the article ‘With Cannabis Now Legal in Canada, Investors Are Turning South to the Largest Emerging Cannabis Market in the World’

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

[Frederick_Chabot]

50k Tonnes par année.

Chemistree Submits Continuous Use Permit Application for Desert Hot Springs, California Cultivation and Processing Permit

VANCOUVER, Nov. 29, 2018 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the « Company » or « Chemistree ») is pleased to announce that the application requesting receipt of a Continuous Use Permit for a Cannabis Cultivation, Processing and Distribution Facility has been submitted to the City of Desert Hot Springs, California.

Chemistree has submitted plans that include two separate cultivation buildings totaling 127,960 square feet and an additional 119,960 square foot building intended for warehousing and processing facilities.

Fully constructed, a facility of this size has the potential to produce approximately 50,000 pounds of cannabis flower per year.

Chemistree president Karl Kottmeier commented, « I am really pleased to see our plans for the Desert Hot Springs property we purchased only several months ago be so quickly advanced. Our team of experienced consultants has done a great job and we are grateful to the city of Desert Hot Springs and the numerous local first responders and service providers for their receptive attitude to our submission. We are looking forward to receipt of final approval so we can begin construction. »

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of « medical cannabis » and « recreational cannabis » do not exist under U.S. federal law. The Federal Controlled Substances Act classifies « marihuana » as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE.

« Karl Kottmeier »
President

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as « anticipate », « believe », « plan », « estimate », « expect », « budget », « scheduled » and « intend », statements that an action or event « may », « might », « could », « should », or « will » be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about adding clients, building on the Company’s initial product offerings, entry into of definitive agreements. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/chemistree-submits-continuous-use-permit-application-for-desert-hot-springs-california-cultivation-and-processing-permit-300757377.html

SOURCE Chemistree Technology Inc.

[Frederick_Chabot]

Chemistree Provides Washington State Operations Update

Je m’initie au monde des influenceurs. Pour le moins surprenant comme dynamique!

VANCOUVER, Dec. 4, 2018 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the « Company » or « Chemistree ») is pleased to announce the following significant developments as provided by its licensee partner managing the cultivation, processing and delivery to points of sale of the Sugarleaf branded suite of products.

Sugarleaf Product Development

Sugarleaf is pleased to now have 18 different strains of high-quality cannabis being grown in rotation, including 9 major strains in high production and 9 minor strains in smaller batch production. Traditionally a producer of high-quality cannabis flower products, Sugarleaf is now pleased to report that it is soon to launch its own line of cannabis oil-based products, to be dispensed in a special edition Sugarleaf branded Vapor Slide V2. The Vapor Slide V2 is a revolutionary distillate vaporizer that is the perfect hybrid between pen and dab. This is an exciting product as concentrates typically sell at a much higher price per gram than flower-based products and products similar to this account for approximately half of all cannabis sales in Washington State. This will be Sugarleaf’s first product launch into the concentrates market and plans are already in place to expand the Sugarleaf brand into other products and devices before the end of Q1, 2019.

Sugarleaf Team Marketing Events

On November 28, Sugarleaf was pleased to host Joel from CustomGrow420, a hugely popular YouTube channel with over 1.6 million subscribers. Joel conducted an extensive video walkthrough of the revamped Sugarleaf operation, providing his subscribers with an in depth look at the various strains under cultivation and an interview with Chemistree Chairman, Justin Chorbajian. This video tour has now been released on YouTube and can be found here: https://www.youtube.com/watch?v=7FOFp-7E2P0

Sugarleaf and Chemistree were also co-sponsors of the High Times magazine party held during the MJBiz cannabis conference held November 14-16 in Las Vegas. This event was a huge success and provided significant exposure for both the Sugarleaf brand and Chemistree as a growing player in the US cannabis market.

The Sugarleaf team was recently host to writers from Dope Magazine, one of the largest global media publications in the cannabis industry. Sugarleaf team members proudly displayed the Sugarleaf facility and appeared in a 2-page article in Dope Magazine’s October 2018 issue. The story « Sugarleaf Goes Green and Makes an Impact » is available at www.sugarleaf.com.

Through a series of targeted initiatives, Sugarleaf recently hosted a group of Bud Tenders from one of the largest retailers in Washington State to celebrate a brand-new event called « High In The Sky ». Sugarleaf introduced its new brands to these important industry people while enjoying a tour of the newly revamped Sugarleaf facility as well as a helicopter ride over the scenic San Juan Islands. More « High In The Sky » events are planned for the near future to continue to expand the Sugarleaf brand.

Grow Facility Update

Chemistree is also pleased to report that the Sugarleaf facility has undergone significant infrastructure upgrades and design improvements, including the addition of an automated irrigation system allowing the Sugarleaf cannabis product to be grown more consistently, maintaining its high-quality standard while simultaneously reducing labour costs. Operational performance and improvements include introducing new nutrient feed programs by Green Planet Nutrients custom tailored to fit high yield plant growth, changing growing methods to allow for less labour and higher plant count which will generate larger yields, and the introduction of new genetics.

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of « medical cannabis » and « recreational cannabis » do not exist under U.S. federal law. The Federal Controlled Substances Act classifies « marihuana » as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE.

« Karl Kottmeier »
President

[Frederick_Chabot]

Chemistree Acquires Global Rights to Sugarleaf Brand, Enters California Market

Intégration Verticale.

VANCOUVER, Dec. 6, 2018 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the « Company » or « Chemistree ») is pleased to announce that it has now entered into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State).

Chemistree is now underway with establishing the Sugarleaf brand in California, initially via the strategic collaboration recently launched with the Humboldt County-based cannabis processing company (see press release dated November 27, 2018). The Company is currently focused on product development, biomass sourcing and sales and marketing planning as well as adding key people to the new Chemistree California team. Demand for cannabis in California is increasing rapidly and having a recognizable brand that can drive consumer loyalty will benefit the Company in what is a challenging retail environment.

Karl Kottmeier, Chemistree’s President, commented « I am really pleased to make this announcement. This is a significant advancement for Chemistree’s growth plans and I am grateful to our tremendous team of advisors in California who are helping us access a market that is expected to exceed $5.1 billion next year. Sugarleaf is a high quality, flower-based product line in Washington state and now, working closely with our new processor partner in Humboldt, we will be able to develop and produce Sugarleaf manufactured products as well as flower products in the world’s sixth largest economy – the massive California market. »

For more information on the Sugarleaf brand and related products, please visit www.sugarleaf.com.

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. and international cannabis sector, providing turn key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a first investment in the Canadian cannabis sector through Pasha Brands and has a robust pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of « medical cannabis » and « recreational cannabis » do not exist under U.S. federal law. The Federal Controlled Substances Act classifies « marihuana » as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company following the completion of the acquisitions, and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the Form 2A listing statement filed with the CSE and the Company’s annual information form available under its profile on SEDAR at www.sedar.com.

« Karl Kottmeier »
President

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as « anticipate », « believe », « plan », « estimate », « expect », « budget », « scheduled » and « intend », statements that an action or event « may », « might », « could », « should », or « will » be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about adding clients, building on the Company’s initial product offerings, negotiation of a line of credit for working capital purposes with the Processor, the expected uses of the Loan proceeds by the Processor, growth and expansion of the Processor’s business, and the benefits to Chemistree of the Collaboration. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators, including under the heading « Risk Factors » in its annual information form dated September 28, 2018 for the fiscal year ended June 30, 2018 available under the Company’s profile on SEDAR at www.sedar.com. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/chemistree-acquires-global-rights-to-sugarleaf-brand-enters-california-market-300761255.html

SOURCE Chemistree Technology Inc.

[Frederick_Chabot]

Interview de Karl Kotmeier. Belle introduction sur une équipe qui surprendra énormément Q1 2019

[Frederick_Chabot]

On me dit que le montant sera entre $10 et 15M

Chemistree announces short-form prospectus offering of debenture units

VANCOUVER, Feb. 5, 2019 /CNW/ - Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the " Company " or " Chemistree ") announced today that it has filed a preliminary short form prospectus in each of the provinces of Canada, other than Québec, in connection with a « best efforts » offering (the " Offering ") of debenture units of the Company (the " Initial Units ") at a price of $1,000 per Initial Unit (the " Offering Price "). Canaccord Genuity Corp. (the " Agent ") will act as sole book-runner and agent in respect of the Offering. The number of the Initial Units to be sold pursuant to the Offering will be determined through discussions between the Company and the Agent, in the context of the market.

The Company has granted to the Agent an option (the " Over-Allotment Option "), exercisable from time to time in whole or in part, in the sole discretion of the Agent, up to 30 days from the closing of the offering (the " Closing Date "), to purchase up to an additional 15% of the number of Initial Units sold pursuant to the Offering on the same terms as set forth above to cover over-allotments, if any (the " Additional Units " and together with the Initial Units, the " Debenture Units ").

Each Debenture Unit will consist of (i) one 10% unsecured convertible debenture of the Company in the principal amount of $1,000 (each, a " Debenture ") with interest payable semi-annually in arrears on June 30 and December 31 of each year, commencing June 30, 2019 (each, an " Interest Payment Date ") and maturing three years from the date the Debentures are issued (the " Maturity Date "), and (ii) 2,000 warrants (each, a " Warrant "), each Warrant being exercisable for a period of three years following the Closing Date to purchase one common share of the Company (each, a " Warrant Share ") at an exercise price of $0.70 per Warrant Share, subject to adjustment in certain events.

Each Debenture will be convertible at a price of $0.50 per Debenture (the " Conversion Price ") at the option of the holder (each, a " Debentureholder ") into common shares of the Company (the " Debenture Shares ") at any time prior to the earlier of: (i) the last business day immediately preceding the Maturity Date; and (ii) the business day immediately preceding the date specified for redemption of the Debentures upon a change of control, subject to acceleration in certain events. Upon conversion, Debentureholders will receive accrued and unpaid interest thereon for the period from and including the date of the latest Interest Payment Date to, and including, the date of conversion.

The Company may force the conversion of the principal amount of the then outstanding Debentures at the Conversion Price on not less than 30 days’ notice should the daily volume weighted average trading price of the Company’s outstanding common shares (the " Common Shares ") on the Canadian Securities Exchange (the " CSE ") be equal to or greater than $1.00 per Common Share for any 10 consecutive trading days, subject to such mandatory conversion being permitted under the policies of the applicable exchange at the time of conversion.

Upon a change of control of the Company, Debentureholders will have the right to require the Company to repurchase their Debentures, in whole or in part, on the date that is 30 days following the giving of the notice of change of control, at a price equal to 104% of the principal amount of the Debentures then outstanding plus accrued and unpaid interest thereon (the " Offer Price "). If 90% or more of the principle amount of the Debentures outstanding are tendered for redemption, the Company will have the right to redeem all of the remaining Debentures at the Offer Price.

The Company has agreed to pay a cash commission (the " Agent’s Fee ") to the Agent equal to 7.0% of the gross proceeds of the Offering, including in respect of any Additional Units issued upon exercise of the Over-Allotment Option. As additional consideration for the services rendered in connection with the Offering, the Company has agreed to: (a) pay the Agent, on the Closing Date, a corporate finance fee of $150,000 (the " Corporate Finance Fee "), of which $75,000 will be paid in cash and $75,000 will be satisfied through the issuance of Common Shares at the Conversion Price; and (b) issue to the Agent, on the Closing Date, non-transferable broker warrants (the " Broker Warrants ") to purchase such number of units of the Company (collectively, the " Broker Units ") as is equal to 7.0% of the number of Debenture Shares that would be issued assuming the conversion of 100% of the Debentures sold under the Offering (including any Additional Units issuable upon exercise of the Over-Allotment Option), at $0.50 per Broker Unit. Each Broker Unit will consist of one Common Share (each, a " Broker Unit Share ") and one-half of one Common Share purchase warrant of the Company (each whole warrant, a " Broker Unit Warrant "). Each Broker Unit Warrant will be exercisable to acquire one Common Share (each, a " Broker Warrant Share ") at any time up to 36 months following the Closing Date at an exercise price of $0.70 per Broker Warrant Share, subject to adjustment in certain events.

The Company will apply to list the Warrants, the Debenture Shares, the Warrant Shares, the Broker Unit Shares, the Broker Unit Warrants and the Broker Warrant Shares to be issued in connection with the Offering on the CSE.

The Company intends to use the net proceeds of the Offering to (i) expand its facilities in Washington State; (ii) expand its brands in California, including the launch of « Sugarleaf » branded products; (iii) continue the licensing, development, and ultimately the build-out, of the Company’s property in Desert Hot Springs, California (the " DHS Property "); and (iv) for working capital and general corporate purposes.

The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the CSE, and the entering into of an agency agreement by the Company and the Agent.

The Debenture Units, Debentures, Warrants, Debenture Shares, Warrant Shares, Broker Warrants, Broker Units, Broker Unit Shares, Broker Unit Warrants and Broker Warrant Shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act "), or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an available exemption from the registration requirement of the U.S. Securities Act and applicable U.S. state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Debenture Units, Debentures, Warrants, Debenture Shares, Warrant Shares, Broker Warrants, Broker Units, Broker Unit Shares, Broker Unit Warrants or Broker Warrant Shares, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a 50% interest in a Humboldt County, California cannabis processing company, has completed its first investment in the Canadian cannabis sector through its investment in Pasha Brands and has a pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory

The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws

The concepts of « medical cannabis » and « recreational cannabis » do not exist under U.S. federal law. The Federal Controlled Substances Act classifies « marihuana » as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defence to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the preliminary short form prospectus of the Company filed in respect of the Offering, the Company’s annual information form and other documents incorporated by reference therein and in the Company’s Form 2A listing statement filed with the CSE and available under the Company’s profile on SEDAR at www.sedar.com.

« Karl Kottmeier »
President

Information set forth in this news release includes forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as « anticipate », « believe », « plan », « estimate », « expect », « budget », « scheduled » and « intend », statements that an action or event « may », « might », « could », « should », or « will » be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements relating to: the Offering, including the receipt in a timely manner, of regulatory and other required approvals and clearances, including the approval of the CSE; the number of Debenture Units to be sold; the gross proceeds of the Offering; the number of Debentures to be issued and sold by the Company; the payment of interest and the principal amount, and the conversion or exercise of other rights attached to the Debentures, the Warrants, the Broker Warrants, the Broker Units and the Broker Unit Warrants; the listing of the Warrants, Debenture Shares, Warrant Shares, Broker Unit Warrants and Broker Unit Shares on the CSE; the payment of the Agent’s Fee and Corporate Finance Fee; the exercise of the Over-Allotment Option; and the use of the net proceeds of the Offering.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: establishing a trading market for the Debenture and Warrants; fluctuations in the market price of the Common Shares, Debentures and Warrants; risks relating to the dilution of the Common Shares, Debentures and Warrants; risks and uncertainties relating to the actual use of the net proceeds of the Offering; changes in market conditions; an exchange on which the Company’s shares are listed may initiate a delisting review; stock price volatility; sales by shareholders of a substantial number of Common Shares, Debentures or Warrants; the failure to sign agreements with a strategic partner in respect of the Company’s facilities in Washington State; the failure to obtain required regulatory approvals in respect of the DHS Property; the failure to complete the Company’s proposed loan to a Humboldt County-based cannabis processing company located in Arcata, California; and the risks identified in the Company’s reports and filings with the applicable Canadian securities regulators, including, without limitation, all risks in and incorporated by reference into the Company’s preliminary short-form prospects in respect of the Offering.

Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Chemistree Technology Inc.

[Frederick_Chabot]

Chemistree Granted Conditional Use Permit for Desert Hot Springs Land

VANCOUVER, Feb. 19, 2019 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the « Company » or « Chemistree ») is pleased to report that its wholly-owned subsidiary, CHM Desert, LLC, has been granted a Conditional Use Permit (« CUP ») by the City of Desert Hot Springs for its 9.55 acre property in located in the City’s cannabis cultivation-friendly zone (« Green Zone »).

The CUP encompasses cultivation in two greenhouse buildings totaling approximately 128,000 square feet, and an additional building of up to an additional 40,000 square feet for processing, manufacturing and distribution of cannabis goods. Fully constructed, the Company expects that a facility of this size has the potential to produce approximately 50,000 pounds of dried-cannabis flower per year and, once fully licensed and constructed, will have the capacity to process, manufacture and distribute a range of cannabis-related products.

Chemistree’s President, Karl Kottmeier commented « I am really proud of our California team for getting this CUP from concept to award in less than seven months. The City of Desert Hot Springs has proven to be a terrific partner, and we look forward to commencing site works as soon as the permitting process allows. Our team has a track record of successfully building cultivation facilities in Desert Hot Springs and we are planning to move our project forward as aggressively as possible. »

About Chemistree Technology Inc.
Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. The Company currently owns assets in Washington State used to operate the Sugarleaf brand, prospective cannabis cultivation lands in California, a 50% interest in a Humboldt County, California cannabis processing company, has completed its first investment in the Canadian cannabis sector through its investment in Pasha Brands and has a pipeline of assets to grow its base of business. For more information, visit www.chemistree.ca.

Advisory
The Company wishes to inform shareholders that there are significant legal restrictions and regulations that govern the cannabis industry in both Canada and the United States.

Cannabis-related Practices or Activities are Illegal Under U.S. Federal Laws
The concepts of « medical cannabis » and « recreational cannabis » do not exist under U.S. federal law. The Federal Controlled Substances Act classifies « marihuana » as a Schedule I drug. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. As such, cannabis related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defence to any federal proceeding which may be brought against the Company. Enforcement of U.S. federal laws will be a significant risk to the business of the Company and any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance.

Further information regarding the legal status of cannabis related activities and associated risk factors, including, but not limited to, risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions cease providing services to the Company, and the risk that Company may not be able to distribute profits, if any, from U.S. operations up to the Company, are included in the preliminary short form prospectus of the Company filed in respect of the Offering, the Company’s annual information form and other documents incorporated by reference therein and in the Company’s Form 2A listing statement filed with the CSE and available under the Company’s profile on SEDAR at www.sedar.com.

« Karl Kottmeier »
President